In the past five years, Kim Wever has focussed her translational research on the development of new treatment strategies against ischemia-reperfusion injury. Using in vivo models in animals and humans, she investigated ischemic conditioning strategies against ischemic damage in the kidney, muscle and heart, and unravelled signalling pathways involved. In the last three years, she became exceedingly aware of the need to improve the translational value of animal models in pre-clinical science, which has now become the focus of her work. She is an expert on systematic reviews and meta-analyses of preclinical studies and develops specialized methodology for this approach. Through her position at SYRCLE, based within the Central Animal Laboratory, and close collaboration with i.a. the department of Surgery, she is able to directly apply the evidence synthesized through systematic review in the design and practice of (pre-)clinical studies.
National & International Personal Prizes & Awards
- 2014-present: Participant in the Radboud Galilei Track, a 5-year talent track for excellent postdoc's of the Radboud university medical center.
- 2013: best poster award at the 2nd International Symposium and Workshop on Systematic Reviews in Laboratory Animal Science, Edinburgh, UK
- 2007: Prof. Van Nieuwenhoven prize awarded yearly by the Radboud University faculty of science to the student with the best MSc in biosciences
<< go back